Dropprint Genomics

Dropprint Genomics is a pioneering company in the field of single-cell genomics, founded in 2019 and later acquired by Immunai in 2021. The company focuses on transforming drug discovery through precision biology by leveraging advanced computational platforms to analyze individual immune cells. Their technology allows for unprecedented scale in the analysis of immune cells, achieving a tenfold reduction in costs compared to traditional methods. This innovation enables researchers to unlock insights that were previously unattainable with conventional approaches to genomics, which typically aver…